{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:20:30Z","timestamp":1789132830941,"version":"build-2803163510"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:p>\n                    X-linked immunodeficiency with magnesium defect, Epstein-Barr virus (EBV) infection, and neoplasia (XMEN) is an extremely rare inborn error of immunity (IEI) caused by X-linked recessive inheritance and loss-of-function mutations in the\n                    <jats:italic toggle=\"yes\">MAGT1<\/jats:italic>\n                    gene, resulting in magnesium ion channel defects. This article reports 2 cases of systemic EBV-positive T-cell Lymphoma of childhood (SETLC) associated with XMEN, which have not been reported before. Whole exome sequencing (WES) in their family revealed previously unreported\n                    <jats:italic toggle=\"yes\">MAGT1<\/jats:italic>\n                    gene mutations (c.77T&gt;C, p.I26T; c.956-957del: p.Ser319Tyrfs) inherited from their mothers. These mutations expand the spectrum of gene mutations in XMEN disease. The importance of genetic testing for\n                    <jats:italic toggle=\"yes\">MAGT1<\/jats:italic>\n                    mutations in the initial diagnosis of SETLC was emphasized. We also review the literature on this uncommon IEI.\n                  <\/jats:p>","DOI":"10.1097\/mph.0000000000002940","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T19:46:29Z","timestamp":1724874389000},"page":"356-363","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["XMEN-associated Systemic EBV-positive T-cell Lymphoma of Childhood: Report of Two Cases and Literature Review"],"prefix":"10.1097","volume":"46","author":[{"given":"Ping","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0378-2410","authenticated-orcid":false,"given":"Yang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junye","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3505-0302","authenticated-orcid":false,"given":"Xiaowen","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"R3-20250804","first-page":"416","article-title":"Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report","volume":"95","author":"Reiter","year":"2000","journal-title":"Blood"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","article-title":"Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study","volume":"29","author":"Yamaguchi","year":"2011","journal-title":"J Clin Oncol"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1182\/blood-2013-11-538686","article-title":"XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus","volume":"123","author":"Li","year":"2014","journal-title":"Blood"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10875-014-0116-2","article-title":"Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease","volume":"35","author":"Dhalla","year":"2015","journal-title":"J Clin Immunol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.clim.2015.04.015","article-title":"A case of XMEN syndrome presented with severe auto-immune disorders mimicking autoimmune lymphoproliferative disease","volume":"159","author":"Patiroglu","year":"2015","journal-title":"Clin Immunol"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10875-016-0341-y","article-title":"Large deletion of MAGT1 gene in a patient with classic Kaposi sarcoma, CD4 lymphopenia, and EBV infection","volume":"37","author":"Brigida","year":"2017","journal-title":"J Clin Immunol"},{"key":"R9-20250804","first-page":"48","article-title":"X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia: report of a family and literature review","volume":"56","author":"He","year":"2018","journal-title":"Chin J Pediatr"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-018-0573-0","article-title":"Successful bone marrow transplantation for XMEN: hemorrhagic risk uncovered","volume":"39","author":"Dimitrova","year":"2019","journal-title":"J Clin Immunol"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"9865","DOI":"10.1073\/pnas.1817815116","article-title":"Mutations in MAGT1 lead to a glycosylation disorder with a variable phenotype","volume":"116","author":"Blommaert","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10875-020-00746-1","article-title":"The many faces of XMEN disease, report of two patients with novel mutations","volume":"40","author":"Hoyos-Bachiloglu","year":"2020","journal-title":"J Clin Immunol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10875-019-00732-2","article-title":"Diversity of XMEN disease: description of 2 novel variants and analysis of the lymphocyte phenotype","volume":"40","author":"Klinken","year":"2020","journal-title":"J Clin Immunol"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"653266","DOI":"10.3389\/fonc.2021.653266","article-title":"Case report: EBV-positive extra-nodal marginal zone lymphoma associated with XMEN disease caused by a novel hemizygous mutation in MAGT1","volume":"11","author":"Huang","year":"2021","journal-title":"Front Oncol"},{"key":"R15-20250804","first-page":"92","article-title":"Scales of Magt1 gene: novel mutations, different presentations","volume":"21","author":"Haskologlu","year":"2022","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41435-022-00166-8","article-title":"Identification of a novel MAGT1 mutation supports a diagnosis of XMEN disease","volume":"23","author":"Watson","year":"2022","journal-title":"Genes Immun"},{"key":"R17-20250804","first-page":"2390167","article-title":"Novel MAGT1 mutation found in the first Chinese XMEN in Hong Kong","volume":"2022","author":"Au","year":"2022","journal-title":"Case Rep Immunol"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1684\/mrh.2011.0286","article-title":"Loss of MAGT1 abrogates the Mg2+ flux required for T cell signaling and leads to a novel human primary immunodeficiency","volume":"24","author":"Li","year":"2011","journal-title":"Magnes Res"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1126\/science.1240094","article-title":"Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D","volume":"341","author":"Chaigne-Delalande","year":"2013","journal-title":"Science"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature10246","article-title":"Second messenger role for Mg2+ revealed by human T-cell immunodeficiency","volume":"475","author":"Li","year":"2011","journal-title":"Nature"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fped.2019.00071","article-title":"Epstein-Barr virus-associated T and NK-cell lymphoproliferative diseases","volume":"7","author":"Kim","year":"2019","journal-title":"Front Pediatr"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00428-023-03616-4","article-title":"Cytotoxic peripheral T-cell lymphomas and EBV-positive T\/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP\/SH lymphoma workshop","volume":"483","author":"Climent","year":"2023","journal-title":"Virchows Arch"},{"key":"R23-20250804","first-page":"1131","article-title":"Clinicopathological analysis of children\u2019s systemic EBV-positive T-cell lymphoma","volume":"27","author":"Zhu","year":"2019","journal-title":"J Exp Hematol"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1532\/IJH97.07012","article-title":"Nationwide survey of HLH in Japan","volume":"86","author":"Ishii","year":"2007","journal-title":"Int J Hematol"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"key":"R26-20250804","first-page":"997","article-title":"Consensus recommendations for the diagnosis and management of HLH associated with malignancies","volume":"100","author":"Lehmberg","year":"2015","journal-title":"Haematologica"},{"key":"R27-20250804","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.humpath.2015.03.002","article-title":"Epstein-Barr virus-positive nodal T\/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features","volume":"46","author":"Jeon","year":"2015","journal-title":"Hum Pathol"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s12185-016-2068-1","article-title":"Clinical features and treatment outcome of Epstein-Barr virus-positive nodal T-cell lymphoma","volume":"104","author":"Jung","year":"2016","journal-title":"Int J Hematol"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3960\/jslrt.20001","article-title":"Nodal EBV+ cytotoxic T-cell lymphoma: a literature review based on the 2017 WHO classification","volume":"60","author":"Kato","year":"2020","journal-title":"J Clin Exp Hematop"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3324\/haematol.2021.280003","article-title":"Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T\/NK-cell lymphoma from ENKTL and PTCL-NOS","volume":"107","author":"Wai","year":"2022","journal-title":"Haematologica"},{"key":"R31-20250804","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s10875-021-01137-w","article-title":"A double-blind, placebo-controlled, crossover study of magnesium supplementation in patients with XMEN disease","volume":"42","author":"Chauvin","year":"2022","journal-title":"J Clin Immunol"},{"key":"R32-20250804","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1182\/blood.2021011192","article-title":"CRISPR-targeted MAGT1 insertion restores XMEN patient hematopoietic stem cells and lymphocytes","volume":"138","author":"Brault","year":"2021","journal-title":"Blood"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002940","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:02:04Z","timestamp":1754337724000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002940","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"2024-02-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}